Clinical trial
Study of Antibiotics in the Treatment of Colonic Crohn's Disease
NCT00257699 · Mount Sinai Hospital, Canada, Other · Terminated
Key facts
| NCT number | NCT00257699 |
|---|---|
| Title | Study of Antibiotics in the Treatment of Colonic Crohn's Disease |
| Official title | Metronidazole and Ciprofloxacin in the Treatment of Colonic Crohn's Disease: The MACINTOCC Trial. |
| Lead sponsor | Mount Sinai Hospital, Canada, Other |
| Collaborators | Crohn's and Colitis Foundation |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Crohn's Disease |
| Intervention type | Drug |
| Interventions | Metronidazole placebo, ciprofloxacin placebo, ciprofloxacin, metronidazole |
| Enrollment | 12 |
| Start date | May 1, 2006 |
| Primary completion | Jul 1, 2008 |
| Completion | Jul 1, 2008 |
| First posted | Nov 23, 2005 |
| Last update posted | Aug 12, 2008 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: